Literature DB >> 11007198

Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.

C J Fisher1, S B Yan.   

Abstract

OBJECTIVE: To consider the appropriateness of protein C levels as a prognostic indicator for sepsis and related diseases. DATA SOURCES/STUDY SELECTION: Published research and review articles related to protein C deficiency in patients with sepsis and related diseases. DATA EXTRACTION AND SYNTHESIS: All applicable data were extracted, and relevant literature was cited to support factual statements in the text. The protein C pathway represents one of the major regulatory systems of hemostasis, exhibiting antithrombotic, profibrinolytic, and anti-inflammatory properties. Numerous studies have shown that acquired protein C deficiency is prevalent in the majority of septic patients (>85%) and is associated with increased morbidity and mortality in patients with severe sepsis and septic shock. This deficiency in protein C is not simply a transient marker for sepsis, but parallels the progress of the disease. In addition, protein C deficiency occurs in the presence of a wide range of pathogens and develops early in the disease process.
CONCLUSIONS: A review of the relevant literature suggests that protein C levels may serve as a useful prognostic indicator of outcome in sepsis and related diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007198     DOI: 10.1097/00003246-200009001-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  40 in total

1.  Plasma antithrombin III and protein C levels in early recognition of late-onset sepsis in newborns.

Authors:  Ryszard Lauterbach; Dorota Pawlik; Renata Radziszewska; Joanna Woźniak; Krzysztof Rytlewski
Journal:  Eur J Pediatr       Date:  2006-04-25       Impact factor: 3.183

2.  Drotrecogin alfa (activated): the first FDA-approved treatment for severe sepsis.

Authors:  Anita Marie Hosac
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-04

3.  Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population.

Authors:  Qi Xing Chen; Shui Jing Wu; Hai Hong Wang; Chen Lv; Bao Li Cheng; Guo Hao Xie; Xiang Ming Fang
Journal:  Hum Genet       Date:  2008-02-05       Impact factor: 4.132

4.  Coagulation parameters in the patients with Fournier's Gangrene.

Authors:  Hayrettin Sahin; Ugur Aflay; Nihal Kilinç; Mehmet Kamuran Bircan
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

5.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

6.  Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency.

Authors:  Angelina J Lay; Deborah Donahue; Meng-Ju Tsai; Francis J Castellino
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

7.  Protein C concentrate to restore physiological values in adult septic patients.

Authors:  Fabio Baratto; Flavio Michielan; Muzio Meroni; Antonella Dal Palù; Annalisa Boscolo; Carlo Ori
Journal:  Intensive Care Med       Date:  2008-05-06       Impact factor: 17.440

8.  Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study.

Authors:  Rakshit Panwar; Bala Venkatesh; Peter Kruger; Robert Bird; Devinder Gill; Leo Nunnink; Goce Dimeski
Journal:  J Hematol Oncol       Date:  2009-10-19       Impact factor: 17.388

Review 9.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

10.  Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study.

Authors:  Federico Pappalardo; Martina Crivellari; Ambra L Di Prima; Nataliya Agracheva; Malgorzata Celinska-Spodar; Rosalba Lembo; Daiana Taddeo; Giovanni Landoni; Alberto Zangrillo
Journal:  Intensive Care Med       Date:  2016-06-25       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.